Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Boldrini

Showing results (101-110 of 233) with videos related to

Pageof 24
Sort By:
Clinical & Experimental Metastasis|April 26, 2026
Magnetic resonance-guided stereotactic body radiotherapy (MRIgSBRT) for nodal disease in oligometastatic setting: a single-institution studyGiuditta Chiloiro, Giulia Panza, Angela Romano, et al.
Physics in Medicine and Biology|March 24, 2022
Offline and online LSTM networks for respiratory motion prediction in MR-guided radiotherapyElia Lombardo, Moritz Rabe, Yuqing Xiong, et al.
Journal of Applied Clinical Medical Physics|October 22, 2020
Quantitative analysis of MRI-guided radiotherapy treatment process time for tumor real-time gating efficiencyLorenzo Placidi, Davide Cusumano, Luca Boldrini, et al.
Journal of Cancer Research and Clinical Oncology|October 1, 2020
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patientsGian Carlo Mattiucci, Luca Boldrini, Alessia Nardangeli, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment RadiomodulationFederico Iori, Alessio Bruni, Salvatore Cozzi, et al.
Radiation Oncology (London, England)|April 16, 2022
Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohortLuca Boldrini, Jacopo Lenkowicz, Lucia Clara Orlandini, et al.
Critical Reviews in Oncology/Hematology|July 14, 2025
Gender differences in radiotherapy: A critical reviewEmma D'Ippolito, Roberta Grassi, Cristiano Grossi, et al.
Technical Innovations & Patient Support in Radiation Oncology|February 26, 2020
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanningGian Carlo Mattiucci, Luca Boldrini, Lorenzo Placidi, et al.
Reviews on Recent Clinical Trials|May 20, 2022
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?Filippo Lococo, Marco Chiappetta, Corolina Sassorossi, et al.
Journal of Cancer Research and Clinical Oncology|January 5, 2021
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approachLuca Boldrini, Angela Romano, Silvia Mariani, et al.
Pageof 24

Showing results (101-110 of 233) with videos related to

Sort By:
Pageof 24
Clinical & Experimental Metastasis|April 26, 2026
Magnetic resonance-guided stereotactic body radiotherapy (MRIgSBRT) for nodal disease in oligometastatic setting: a single-institution studyGiuditta Chiloiro, Giulia Panza, Angela Romano, et al.
Physics in Medicine and Biology|March 24, 2022
Offline and online LSTM networks for respiratory motion prediction in MR-guided radiotherapyElia Lombardo, Moritz Rabe, Yuqing Xiong, et al.
Journal of Applied Clinical Medical Physics|October 22, 2020
Quantitative analysis of MRI-guided radiotherapy treatment process time for tumor real-time gating efficiencyLorenzo Placidi, Davide Cusumano, Luca Boldrini, et al.
Journal of Cancer Research and Clinical Oncology|October 1, 2020
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patientsGian Carlo Mattiucci, Luca Boldrini, Alessia Nardangeli, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment RadiomodulationFederico Iori, Alessio Bruni, Salvatore Cozzi, et al.
Radiation Oncology (London, England)|April 16, 2022
Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohortLuca Boldrini, Jacopo Lenkowicz, Lucia Clara Orlandini, et al.
Critical Reviews in Oncology/Hematology|July 14, 2025
Gender differences in radiotherapy: A critical reviewEmma D'Ippolito, Roberta Grassi, Cristiano Grossi, et al.
Technical Innovations & Patient Support in Radiation Oncology|February 26, 2020
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanningGian Carlo Mattiucci, Luca Boldrini, Lorenzo Placidi, et al.
Reviews on Recent Clinical Trials|May 20, 2022
Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?Filippo Lococo, Marco Chiappetta, Corolina Sassorossi, et al.
Journal of Cancer Research and Clinical Oncology|January 5, 2021
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approachLuca Boldrini, Angela Romano, Silvia Mariani, et al.
Pageof 24